Research for early detection of adverse events of immune checkpoint inhibitors

Prospective research for biomarkers for early detection of immune-related adverse events attributed to immune checkpoint inhibitors - Research for irAE biomarkers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044022

Enrollment

Registered

2021-04-23

Start date

2019-08-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients starting cancer chemotherapy with immune checkpoint inhibitors

Exclusion criteria

Exclusion criteria: Doctor has determined who are not suitable for research

Design outcomes

Primary

Measure	Time frame
Blood concentrations of immunity regulators	—

Countries

Japan

Contacts

Public ContactMaiko Machida

Hokkaido University of Science Pharmaceutical Sciences

machida-m@hus.ac.jp011-676-8652

Outcome results